Login
03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
- General Info
- Route
- ATC
- Indications
- Composition
- Excipients
- Side Effects
- Alternative Products
- AP Price Chart
- Alternative Treatments
-
Contraindicated
Fetal hypothyroidism
Contraindicated
Fetal hypothyroidism
| Amiodarone 50mg/ml : | |
| Type | TAU |
| Originator | Cordarone Ampoules |
| Agent | Medi Drug International |
| Distributor | Medi Drug International |
| Laboratory | Unknown from UK |
| Manufacturer | Unknown Manufacturer |
| Manufacturing Type | G |
| Origin | N/A |
| ATC | C01BD01 |
Amiodarone 50mg/ml :
Amiodarone 50mg/ml :
Amiodarone 50mg/ml :
Amiodarone 50mg/ml :
Amiodarone 50mg/ml :
| Hazard Level |
|---|
| ◼ Major |
| ◼ Moderate |
| ◼ Minor |
| ◼ Safe |
Amiodarone 50mg/ml :
| Frequency | Percentage |
|---|---|
| Very Common | ≥ 1/10 |
| Common | ≥ 1/100 - < 1/10 |
| Uncommon | ≥ 1/1,000 - < 1/100 |
| Rare | ≥ 1/10,000 - < 1/1,000 |
| Very Rare | < 1/10,000 |
| Unknown | Cannot be Estimated |
| Effect | Frequency |
|---|---|
| Adult respiratory distress syndrome | Very rare |
| Agranulocytosis | Not known |
| Anaphylactic shock | Very rare |
| Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
| Apnoea (Apnea) | Very rare |
| Arrhythmia | Very rare |
| Back pain | Not known |
| Benign intracranial hypertension | Very rare |
| Bradycardia | Common |
| Bronchospasm | Very rare |
| Cardiac arrest | Very rare |
| Cephalea | Very rare |
| Collapse | Common |
| Confusion | Not known |
| Delirium | Not known |
| Dermatitis bullous | Not known |
| DRESS (Drug reaction with eosinophilia and systemic symptoms) | Not known |
| Eczema | Common |
| Hallucination | Not known |
| Hepatic damage | Very rare |
| Hepatic failure (Hepatic insufficiency) (Liver failure) | Very rare |
| Hot flush | Very rare |
| Hyperthyroidism | Not known |
| Hypotension | Common |
| Inappropriate antidiuretic hormone secretion (SIADH) | Very rare |
| Injection site cellulitis | Common |
| Injection site erythema | Common |
| Injection site extravasation | Common |
| Injection site induration | Common |
| Injection site infection | Common |
| Injection site inflammation | Common |
| Injection site necrosis | Common |
| Injection site oedema | Common |
| Injection site pain | Common |
| Injection site phlebitis | Common |
| Injection site pigmentation changes | Common |
| Injection site thrombophlebitis | Common |
| Interstitial pneumonitis | Very rare |
| Jaundice | Very rare |
| Libido decreased | Not known |
| Lyell Syndrome (Toxic epidermal necrolysis) | Not known |
| Nausea | Very rare |
| Neutropenia | Not known |
| Pancreatitis acute | Not known |
| Sinus arrest (Sinus pause) | Very rare |
| Stevens-Johnson syndrome | Not known |
| Sweating | Very rare |
| Torsade de pointes | Not known |
| Transaminases increased | Very rare |
| Urticaria | Not known |
| ▲ Most Expensive |
| ▼ Least Expensive |
| P.P. = | Public Price |
| P/U = | Price Per Unit |
| - Products with same active ingredients |
| - Products with same strength |
| - Products with same route of administration |
| NB : Products With Same Indication |
Different Units By MoH Code
Amiodarone 50mg/ml MoH 2062401 :
| Form | Solution for injection |
| Packaging | Glass Ampoules |
| Package Size | 5x3ml |
| Strength | 150mg |
| Stratum | N/A |
| NSSF | ✘ |
| Quarantine | ✘ |
Price Comparison
- ◼ Lebanon
- ◼ Country of Origin
- ◼ Reference Countries
- ◼ Other Countries
You have to register to view this info
Upload File
Drop File
Uploading, Please wait ....
